Bio Green Med Solution (BGMS) Change in Cash (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Change in Cash of -$166000.0 for Q1 2026, down 153.04% year-over-year from $313000.0 in Q1 2025, and up 50.15% quarter-over-quarter from -$333000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Change in Cash (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Change in Cash for 17 consecutive years, with -$166000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 153.04% year-over-year to -$166000.0; the TTM figure through Mar 2026 stood at -$111000.0 (down 117.02% YoY), while the FY2025 annual figure was $368000.0, up 252.7% from the prior year.
- Change in Cash improved to -$166000.0 in Q1 2026 per BGMS's latest filing, from -$333000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $3.2 million in Q2 2024 and bottomed at -$6.9 million in Q1 2022.
- Historically, Change in Cash has averaged -$2.0 million across 5 years, with a median of -$580000.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Cash jumped 351.93% — and 2025, when it tumbled 314.84%.
- Bio Green Med Solution's Change in Cash stood at -$5.4 million in 2022, then surged by 52.14% to -$2.6 million in 2023, then soared by 106.04% to $155000.0 in 2024, then sank by 314.84% to -$333000.0 in 2025, then soared by 50.15% to -$166000.0 in 2026.
- Business Quant data shows BGMS's Change in Cash at -$166000.0 in Q1 2026, -$333000.0 in Q4 2025, and -$437000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.60 Bn | 133.75 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.38 Bn | 78.38 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.83 Bn | 59.64 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.69 Bn | 52.56 Bn | 52.00 Mn | -185.00 Mn |
| 5 | Revolution Medicines | 44.46 Bn | 44.46 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.31 Bn | 35.21 Bn | 1.53 Bn | 427.25 Mn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Royalty Pharma | 28.12 Bn | 27.28 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.40 Bn | 26.23 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Bio Green Med Solution | 4.95 Mn | 1.16 Mn | 79,000.00 | 451,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 451,000.00 |
| Mar 31, 2026 | -166,000.00 |
| Dec 31, 2025 | -333,000.00 |
| Sep 30, 2025 | -437,000.00 |
| Jun 30, 2025 | 825,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | -3.02 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | -580,000.00 |
| Dec 31, 2023 | -2.57 Mn |
| Sep 30, 2023 | -4.22 Mn |
| Jun 30, 2023 | -1.27 Mn |
| Mar 31, 2023 | -6.91 Mn |
| Dec 31, 2022 | -5.36 Mn |
| Sep 30, 2022 | -5.37 Mn |
| Jun 30, 2022 | -562,000.00 |
| Mar 31, 2022 | -6.92 Mn |
| Dec 31, 2021 | -3.66 Mn |
| Sep 30, 2021 | -3.42 Mn |